Mapping Pathways: Developing evidence-based, people-centred strategies for the use of antiretrovirals as prevention (RAND)

Molly Morgan Jones, a Research Leader in RAND Europe, discusses how antiretroviral (ARV)-based HIV prevention strategies need to be closely tailored to local contexts and cultures in order to make an impact on new HIV infections globally.